Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Infectious Diseases
 More »

  • Companion Diagnostics: 52 Pick-Up
    ... Companies said they expect initial collaborations to focus on cancer, "although they may also explore opportunities in infectious diseases, genetics and other conditions." Specific ...
    5-9-2013
  • Twin Effort Hones In on Membrane Proteins
    They could help in the search for therapies for cancer and infectious, neurodegenerative, metabolic, genetic, and other diseases. However, only about 2% of membrane proteins have ...
    5-1-2013
  • Comparative Genomics: Insights into Disease Susceptibility
    ... several mutations linked with susceptibility to infectious disease and other phenotypes. ... Rhesus macaques ( Macaca mulatta ) are proven models for the study of diseases such as ...
    5-1-2013
  • Merck & Co. Opens Third Manufacturing Plant in China
    ... plant has a capacity of 16 high speed lines to package pharmaceutical tablets and sterile Merck medicines for diabetes, cardiovascular, infectious, respiratory and bone diseases. ...
    4-19-2013
  • Illumina Partnership Eyes Expanded Presence in China
    Among specialties for which Kindstar offers advanced diagnostics are hematology, oncology, infectious diseases, and medical genetics. "Next-generation sequencing is enabling a ...
    4-18-2013
  • BMS, Santaris Make Potentially $100M+ mRNA-Targeting Deal
    against RNA targets, both mRNA and microRNA, for a range of diseases including infectious and inflammatory diseases, cardiometabolic disorders, cancer, and rare genetic disorders. ...
    4-16-2013
  • Roche, Ascletis to Develop HCV Drug in China
    Roche is teaming up with Ascletis, a biotech company focused on new treatments for cancer and infectious diseases, to develop and commercialize Roche's investigational drug and ...
    4-15-2013
  • Triple Threat: New Dx Firm Forged from Three-Company Merger
    Mobidiag today said it will combine with two companies specializing in molecular diagnostics for infectious diseases, after acquiring them for undisclosed prices. The new Mobidiag ...
    4-12-2013
  • Obama Budget: More NIH Grants, Higher FDA User Fees
    However, NIH shifted about $67.9 million of the $194.5 million difference to its National Institute of Allergy and Infectious Diseases (NIAID), toward grants to establish ...
    4-11-2013
  • Inovio Wins $3.5M NIAID Grant to Advance Vaccine Device
    Inovio Pharmaceuticals won a $3.5 million grant from NIH's National Institute of Allergy and Infectious Diseases (NIAID) to advance development of a next-generation DNA vaccine ...
    4-10-2013
  • Five Japanese Pharmas Join Drug-Development Fund
    teaming up with the Bill and Melinda Gates Foundation and Japan's government to develop new medicines, vaccines, and diagnostics for infectious diseases in developing countries. ...
    4-8-2013
  • VaxInnate Wins $2.2M NIAID Grant for Dengue Vaccine
    VaxInnate today said it won a $2.2 million, three-year grant from NIH's National Institute of Allergy and Infectious Diseases (NIAID) to fund the development of a recombinant ...
    4-4-2013
  • Epigenetics Opens New Avenues for DNA Research
    ... In 2012, it was reported that slightly over 20% of all human cancers are causally linked to infectious diseases, and epigenetics played a pivotal role in rekindling and providing a ...
    4-1-2013
  • PrimeraDx on Quest for New Companion Dx
    The companies expect to direct their initial collaborations on cancer, although they may also explore opportunities in infectious diseases, genetics, and other conditions. ...
    3-26-2013
  • Astellas Takes On Dengue with a Little Help from Its Friends
    Under the new agreement with Nagasaki University, the Institute of Tropical Medicine at Nagasaki University (NEKKEN), a research institute focused on tropical infectious diseases, ...
    3-21-2013
  • More »

    Journal Articles

  • Hantaviruses and Their Hosts in Europe: Reservoirs Here and There...
    Gert E. Olsson, Herwig Leirs, Heikki Henttonen
    Vector-Borne and Zoonotic Diseases
    Vector-Borne and Zoonotic Diseases Abstract Five hantaviruses are known to circulate among ... The increasing number of infectious, virus-shedding rodents leads to a rapid transmission ...
  • Vector Competence of Australian Mosquitoes for Chikungunya Virus
    Andrew F. van den Hurk, Sonja Hall-Mendelin, Alyssa T. Pyke, Greg A. Smith, John S. Mackenzie
    Vector-Borne and Zoonotic Diseases
    Vector-Borne and Zoonotic Diseases Abstract Chikungunya virus (CHIKV) is a globally ... In susceptibility trials, the infectious dose required to infect 50% of the ...
  • Zero Prevalence of Influenza A Virus in Two Raptor Species by...
    Gunnar Gunnarsson, Elsa Jourdain, Jonas Waldenström, Björn Helander, Peter Lindberg, Johan Elmberg, Neus Latorre-Margalef, Björn Olsen
    Vector-Borne and Zoonotic Diseases
    Abstract Disease can have severe impact on animal populations, especially in rare species. Baseline data for atypical host species are missing for a range of infectious diseases, ...
  • Seroprevalence and Geographic Distribution of Dirofilaria immitis...
    Viorica Mircean, Mirabela Oana Dumitrache, Adriana Györke, Nikola Pantchev, Robert Jodies, Andrei Daniel Mihalca, Vasile Cozma, Adriana Gyorke
    Vector-Borne and Zoonotic Diseases
    Vector-Borne and Zoonotic Diseases Abstract Tick-borne diseases are of great concern ... The seroprevalence for the four infectious agents were: A. phagocytophilum 5.5% (63/1146), ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll